🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "focused action to address household expense challenges" in the upcoming Budget.

During an interview with media outlets, she noted that curbing price rises is a joint duty of both the administration and the central bank.

The United Kingdom's price growth is expected to be the most elevated among the Group of Seven advanced economies this year and the following year.

Potential Utility Cost Interventions

Sources suggest the government could intervene to bring down utility costs, for instance by cutting the current 5% rate of value-added tax charged on energy supplies.

A further option is to lower some of the regulatory levies presently included in household expenses.

Budgetary Constraints and Analyst Expectations

The administration will obtain the next draft from the official forecaster, the OBR, on Monday, which will reveal how much scope there is for these measures.

The expectation from most economists is that the Chancellor will have to declare tax rises or spending cuts in order to meet her declared debt limits.

Previously on Thursday, calculations suggested there was a £22bn deficit for the Treasury chief to resolve, which is at the lower end of projections.

"It is a collective task between the Bank of England and the government to further reduce some of the sources of inflation," the Chancellor stated to reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Revenue Commitments and International Issues

While much of the focus has been on likely tax rises, the Treasury chief said the most recent figures from the fiscal watchdog had not altered her commitment to election pledges not to raise rates on income tax, VAT or social security contributions.

She attributed an "uncertain global environment" with rising international and trade issues for the Budget tax moves, likely to be directed on those "with the broadest shoulders."

Global Trade Disputes

Commenting on apprehensions about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests always take priority."

Last week's announcement by China to tighten trade restrictions on rare earths and other resources that are key for high-technology manufacturing led US President the US President to propose an further 100% tariff on goods from China, raising the possibility of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary called China's move "economic coercion" and "a international production power grab."

Inquired about considering the American proposal to join its conflict with the Asian nation, Reeves said she was "deeply worried" by China's actions and urged the Chinese government "not to put up barriers and restrict access."

She said the decision was "bad for the world economy and causes further challenges."

"I believe there are fields where we need to challenge China, but there are also important opportunities to export to China's economy, including banking sector and other sectors of the economy. We've got to achieve that balance appropriate."

The chancellor also affirmed she was working with international partners "on our own essential resources approach, so that we are less reliant."

NHS Drug Costs and Funding

The Chancellor also recognized that the cost the NHS pays for medicines could go up as a consequence of current talks with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or canceling operations in the UK, with several blaming the low prices they are getting.

Recently, the Science Minister said the price the NHS pays for medicines would have to increase to prevent firms and drug research funding departing from the United Kingdom.

Reeves informed the BBC: "We have seen because of the pricing regime, that medical research, new drugs have not been provided in the UK in the extent that they are in other EU nations."

"The objective is to make sure that patients receiving treatment from the National Health Service are can access the finest essential drugs in the world. And so we are looking at these issues, and... aiming to attract additional investment into Britain."